Pfizer asks FDA to authorize omicron booster
Pfizer is seeking approval from the FDA to authorize a new COVID vaccine that targets the omicron variant.
Pfizer is seeking approval from the FDA to authorize a new COVID vaccine that targets the omicron variant.